Logo Logo

Publications by Zimmermann, Y.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 4.

Journal article

Fischer, L.; Mayer, A.; Irger, M.; Freysoldt, B.; Zimmermann, Y.; Hutter, G.; Hiddemann, W.; Dreyling, M. (2017): CDK4/6-INHIBITION BY ABEMACICLIB INDUCES POTENT EARLY G1-ARREST IN MCL CELL LINES AND SHOWS SEQUENCE-SPECIFIC INTERACTIONS WITH CYTARABINE AND IBRUTINIB. In: Haematologica, Vol. 102: p. 575

Hutter, G.; Zimmermann, Y.; Zoellner, A.; Irrgang, P.; Arnd, J.; Hiddemann, W.; Dreyling, M. (2016): Mode of action of different PI3K-inhibitors in mantle cell lymphoma. In: Haematologica, Vol. 101: p. 271

Kvint, R.; Zimmermann, Y.; Hutter, G.; Hiddemann, W.; Dreyling, M. (2016): High efficiency of the pan-PI3K/mTOR inhibitor, PQR-309, in MCL. In: Oncology Research and Treatment, Vol. 39: pp. 153-154

Hutter, G.; Zimmermann, Y.; Bamopoulos, S. A.; Irger, M.; Hiddemann, W.; Dreyling, M. (2016): Synergistic effect of inhibition of multiple PI3K-isoforms due to the differential mode of action of single PI3K-isoform inhibitors in mantle cell lymphoma. In: Oncology Research and Treatment, Vol. 39: p. 154

This list was generated on Mon Oct 25 09:01:08 2021 CEST.